Natus Medical Inc (NTUS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
32.96 +0.03 (+0.09%) 07/20/22 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 32.96 unch (unch) -
for Wed, Jul 20th, 2022
Results
download Want to compare other data? Select FieldsSymbol | NTUS | ATEC | TNDM | ||
Company | Natus Medical Inc | Alphatec Holdings | Tandem Diabetes Care | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 32.90 | 11.23 | 17.47 | ||
High | 33.07 | 11.57 | 18.09 | ||
Low | 32.84 | 11.23 | 17.15 | ||
Last | 32.96 | 11.51 | 18.06 | ||
Change | +0.03 | +0.11 | +0.39 | ||
% Change | +0.09% | +0.96% | +2.21% | ||
Volume | 132,600 | 1,056,300 | 1,156,700 | ||
20-Day Average Volume | 233,675 | 2,309,815 | 1,536,730 | ||
Previous Close | 32.93 | 11.40 | 17.67 | ||
Industry | Medical Instruments | Medical Instruments | Medical Instruments | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 32.73 | 10.33 | 17.47 | ||
20-Day Raw Stochastic | 80.00% | 97.65% | 58.33% | ||
20-Day Relative Strength | 57.56% | 59.86% | 41.20% | ||
Weighted Alpha | +27.80 | +11.27 | -54.54 | ||
Today's Opinion | 96% Buy | 72% Buy | 88% Sell | ||
Previous Opinion | 96% Buy | 72% Buy | 88% Sell | ||
Last Month's Opinion | 56% Buy | 40% Buy | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.83% since 07/13/22 | +9.00% since 04/17/25 | +7.12% since 04/17/25 | ||
Low | 32.63 on 07/14/22 | 10.15 on 04/21/25 | 15.95 on 04/21/25 | ||
High | 33.07 on 07/20/22 | 11.57 on 04/25/25 | 18.09 on 04/25/25 | ||
1-Month | |||||
%Chg | +6.05% since 06/17/22 | +11.53% since 03/25/25 | -10.68% since 03/25/25 | ||
Low | 31.10 on 06/21/22 | 8.81 on 04/09/25 | 15.75 on 04/07/25 | ||
High | 33.25 on 06/28/22 | 11.57 on 04/25/25 | 20.30 on 03/26/25 | ||
3-Month | |||||
%Chg | -1.38% since 04/20/22 | +4.54% since 01/24/25 | -50.52% since 01/24/25 | ||
Low | 30.47 on 06/16/22 | 8.81 on 04/09/25 | 15.75 on 04/07/25 | ||
High | 33.57 on 04/26/22 | 12.79 on 03/03/25 | 37.93 on 01/31/25 | ||
6-Month | |||||
%Chg | +37.51% since 01/20/22 | +119.24% since 10/25/24 | -42.39% since 10/25/24 | ||
Low | 20.90 on 02/07/22 | 5.18 on 10/28/24 | 15.75 on 04/07/25 | ||
High | 33.93 on 04/18/22 | 12.79 on 03/03/25 | 38.28 on 01/06/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,133,911 | 1,474,644 | 1,123,584 | ||
Shares Outstanding, K | 34,581 | 144,149 | 66,563 | ||
Annual Sales | 473,440,000 | 611,560,000 | 940,200,000 | ||
Annual Net Income | 13,180,000 | -162,120,000 | -96,030,000 | ||
Last Quarter Sales | 119,790,000 | 176,790,000 | 282,650,000 | ||
Last Quarter Net Income | 1,900,000 | -33,330,000 | 750,000 | ||
60-Month Beta | 0.22 | 1.20 | 1.52 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.22 on 05/05/22 | -0.23 on 02/26/25 | -0.44 on 02/26/25 | ||
Latest Earnings Date | 08/04/22 | 05/01/25 | 04/30/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 25.95 | 0.00 | 0.00 |